openPR Logo
Press release

CD Bioparticles Launches Endotoxin Free Gold Nanoparticles for Biomedical Research and Bioassay Development

10-28-2024 06:32 PM CET | Health & Medicine

Press release from: ABNewswire

CD Bioparticles Launches Endotoxin Free Gold Nanoparticles

CD Bioparticles announces its new Endotoxin Free Gold Nanoparticles for biomedical research and bioassay development.
With years of experience in the pharmaceutical and life science sectors, CD Bioparticles announces the availability of its new Endotoxin Free Gold Nanoparticles [https://www.cd-bioparticles.com/product/endotoxin-free-gold-nanoparticles-356.html] for biomedical research and bioassay development. These nanoparticles offer exceptional biocompatibility and can meet the stringent requirements of researchers and developers working in a variety of fields, including drug delivery, imaging, sensing, medical diagnostics, and therapeutics.

Endotoxin-free gold nanoparticles are specially engineered gold particles with extremely low levels of endotoxin, a toxic substance produced by certain types of bacteria, the presence of which can interfere with experimental results or damage cells or tissues. These nanoparticles are typically coated with citrate to minimize their interaction with biological systems and increase their biocompatibility. Endotoxin-free gold nanoparticles are widely used in biomedical research and bioassay development.

Committed to providing innovative and high-performance biomaterials, CD Bioparticles offers endotoxin-free gold nanoparticles for research applications requiring minimal levels of contamination, such as cytotoxicity studies, immunological studies and sterility testing. The endotoxin content of all batches has been verified by Limulus amebocyte lysate (LAL) testing. These nanoparticles offer exceptional purity and minimal endotoxin contamination to ensure reliable and reproducible results and are suitable for applications such as drug delivery, imaging, and biosensing.

Endotoxin-free gold nanoparticles from CD Bioparticles are available in a range of sizes from 5 nm to 400 nm. These particles exhibit strong light scattering and absorption in the visible and near-infrared regions, making them ideal for various applications. Their renewable nature, excellent thermal, mechanical, and chemical stability, and low toxicity ensure their versatility and safety. Moreover, the surface chemistry of these nanoparticles can be easily modified with biomolecules like antibodies, aptamers, or peptides, enabling precise targeting of specific cells, tissues, or biomolecules.

CD Bioparticles offers a range of functional group/ligand endotoxin free gold nanoparticles to meet diverse research and diagnostic needs, including citric acid-stabilized endotoxin free gold nanoparticles and tannic acid-stabilized endotoxin free gold nanoparticles. For example, the DiagNano Trademark Gold Nanoparticles, Endotoxin Free, 100 nm (Cat. No.BG-100-EF) are citric acid-stabilized gold nanoparticles, with a maximum absorbance of 572 nm, supplied in 0.1 mM phosphate-buffered saline. These nanoparticles boast a purity of over 99.0% and are free of extraneous reactants. With endotoxin levels below 0.5 EU/mL, they are ideal for cellular studies and exhibit exceptional protein binding efficiency. To ensure optimal sterility, the nanoparticles are packaged in dust-free containers, maintaining the highest level of cleanliness.

CD Bioparticles is dedicated to supporting researchers and scientists with their material needs by providing innovative products and exceptional services. These biocompatible nanoparticles offer researchers a powerful tool for advancing their work in a variety of fields. For more information about Endotoxin Free Gold Nanoparticles and other products, please visit https://www.cd-bioparticles.com/product/endotoxin-free-gold-nanoparticles-356.html.

About CD Bioparticles

CD Bioparticles is a leading manufacturer and supplier of various nanoparticles, microparticles, and coatings for R&D as well as commercialization across different application areas, including in vitro diagnostics, biochemistry, cellular analysis, cell separation, and immunoassay. The company also offers various custom services, including chemical surface-functionalization, fluorescent modification, antibody immobilization, as well as nucleic acid and oligo conjugation to meet client specifications.

Media Contact
Company Name: CD Bioparticles
Contact Person: Richard J. Gray
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=cd-bioparticles-launches-endotoxin-free-gold-nanoparticles-for-biomedical-research-and-bioassay-development]
State: New York
Country: United States
Website: https://www.cd-bioparticles.com/



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release CD Bioparticles Launches Endotoxin Free Gold Nanoparticles for Biomedical Research and Bioassay Development here

News-ID: 3712780 • Views:

More Releases from ABNewswire

Edison Awards Winner Kyrin Hall, PhD, Expands AI Conversion Platform
Edison Awards Winner Kyrin Hall, PhD, Expands AI Conversion Platform
Conversion Velocity Engine helps service-based businesses capture and convert leads faster without adding staff Digital marketing innovator and Edison Awards Winner Kyrin Hall, PhD, founder of Digital ShortCutz LLC, announced the expansion of her flagship offering, the Conversion Velocity Engine, an AI-powered marketing and automation system designed to help service-based businesses capture, qualify, and convert leads faster without increasing staff. Hall was recently named a 2026 Edison Awards Winner [https://edisonawards.com/], placing her
See Your Shadow Returns with Powerful New Single
See Your Shadow Returns with Powerful New Single "Another Saturday" - Out May 1, …
PHOENIX, AZ - May 1, 2026 - Multi-award-winning music collective See Your Shadow continues its remarkable run of chart-topping success with the release of their new single, "Another Saturday," arriving everywhere on May 1, 2026. Led by Artistic Director Michael Coleman, See Your Shadow has built a reputation as one of the most consistent and emotionally resonant forces in independent music today. With a staggering streak of eight consecutive chart-topping singles
Predict the 2026 World Cup Winner with This Free Fantasy Bracket App - No Login Required
05-01-2026 | Sports
ABNewswire
Predict the 2026 World Cup Winner with This Free Fantasy Bracket App - No Login …
Bola 2026 lets fans fill in all 104 knockout matches and track predictions against real results. The only free bracket predictor that works without creating an account. With the 2026 FIFA World Cup less than six weeks away, fans looking for a fantasy bracket experience can now use Bola 2026 - a free app that lets users predict every knockout match from the Round of 32 to the Final without creating
Smart Learning Market Revenue Analysis, Growth Factors, Regional Opportunities, Offering & Prominent Players To 2030
Smart Learning Market Revenue Analysis, Growth Factors, Regional Opportunities, …
Smart Learning Market by Hardware (Interactive Displays, Interactive Dashboards, Smart Boards), Software (LMS, LCMS, Student Information System, Classroom Management, Language Learning, Adaptive Learning Platform), Learning Type (Synchronous, Asynchronous), End User (K-12, Higher Education, Enterprise, Government), Region - Global Forecast to 2030. The Smart Learning Market [https://www.marketsandmarkets.com/Market-Reports/smart-digital-education-market-571.html?utm_source=abnewswire.com&utm_medium=referral&utm_campaign=smartdigitaleducationmarket] is expected to expand at a compound annual growth rate (CAGR) of 17.2% from USD 80.69 billion in 2025 to USD 178.62 billion by 2030.

All 5 Releases


More Releases for Bioparticles

CD Bioparticles Simplifies Multi-Analyte Detection with Advanced Multiplex Parti …
CD Bioparticles announces its advanced line of multiplex fluorescence particles. With years of experience in the pharmaceutical and life science sectors, CD Bioparticles announces its advanced line of multiplex fluorescence particles [https://www.cd-bioparticles.com/products/multiplex-assays-466.html] designed to streamline complex biological assays in flow cytometry experiments. These particles exhibit low signal widths in the forward scatter, side scatter and fluorescence channels. Various surface modifications, channels and sizes are also supported. Flow cytometry is a convenient detection
CD Bioparticles Introduces Functional Agarose Particles for Biomedical Research …
CD Bioparticles proudly announces the launch of its new Functional Agarose Particles. With years of experience in the pharmaceutical and life science sectors, CD Bioparticles proudly announces the launch of its new Functional Agarose Particles [https://www.cd-bioparticles.com/products/functional-agarose-particles-1065.html] designed for a variety of applications in the field of bioconjugation, isolation, and purification of biomacromolecules. These particles are ideal for researchers working in areas such as protein purification, antibody production, and nucleic acid isolation. CD
CD Bioparticles Announces Offering of Polystyrene Family Polymers for Drug Deliv …
CD Bioparticles announces the availability of Polystyrene Family polymers for a variety of drug delivery applications. CD Bioparticles, a leading manufacturer and supplier of numerous drug delivery products and services, is pleased to announce the availability of Polystyrene Family polymers [https://www.cd-bioparticles.net/polystyrene-family] for a variety of drug delivery applications. These polymers offer tunable physicochemical properties that enable sustained release profiles and improved drug bioavailability. The polystyrene family, a group of polymers derived from
CD Bioparticles Introduces New Polyolefin Family Polymers for Drug Delivery Appl …
CD Bioparticles announces Polyolefin Family polymers for a variety of drug delivery applications. CD Bioparticles, a leading manufacturer and supplier of numerous drug delivery products and services, has recently expanded its low PDI polymer portfolio and announces its new offering of Polyolefin Family [https://www.cd-bioparticles.net/polyolefin-family] polymers with a wide range of properties that make them well-suited for a variety of drug delivery applications. Low dispersion index polymers are polymeric compounds with low molecular
CD Bioparticles Introduces the Launch of Organic Gold Nanoparticles
With years of experience in the pharmaceutical and life science sector, CD Bioparticles now launches a comprehensive list of organic gold nanoparticles for research applications. These organic gold nanoparticles have a hydrophobic surface character and have great solubility in a wide range of organic solvents. CD Bioparticles offers a comprehensive list of coatings, functional and conjugated gold nanoparticles through precise surface engineering. It offers gold nanoparticles functionalized with reactive groups such
CD Bioparticles Expands Its Biodegradable Polymers Portfolio with Dendrimers
As a leading manufacturer and supplier of various drug delivery products and services, CD Bioparticles recently introduces a series of dendrimers for research use, such as DMPA-G1-TMP-Acetylene, DMPA-G1-TMP-Azide, DMPA-G1-TMP-Carboxyl, and DMPA-G1-TMP-NHBOC. These biodegradable polymers can be used in theranostics, biosensors, optics, adhesives and coatings. With customized delivery strategies, precise designs and modifications of drugs or drug-contained cargos, and advanced technical platforms, CD Bioparticles can help scientists to solve problems in the